• 1. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 2. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 3. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 4. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 5. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615

Exploring the Synthesis and Applications of 1-(tert-Butoxycarbonyl)-1H-indole-5-carboxylic acid (CAS No. 188751-54-4)

The compound 1-(tert-Butoxycarbonyl)-1H-indole-5-carboxylic acid, identified by CAS Registry Number 188751-54-4, represents a structurally complex molecule with significant potential in medicinal chemistry and synthetic biology. This compound combines the aromatic framework of an indole ring with a tert-butoxycarbonyl (Boc) protecting group and a carboxylic acid functionality, creating a versatile scaffold for further functionalization. Recent advancements in its synthesis and application have positioned it as a critical intermediate in the development of novel bioactive compounds.

The indole core, central to this molecule’s structure, is widely recognized for its pharmacological relevance, appearing in drugs such as tryptophan-derived antidepressants and kinase inhibitors. The Boc group, acting as a carbamate protecting group, stabilizes the amine moiety during multi-step syntheses while enabling precise deprotection under mild conditions. This feature is particularly advantageous in solid-phase peptide synthesis and iterative organic transformations. The carboxylic acid functionality further allows for conjugation with other molecules via esterification or amide bond formation, expanding its utility in drug design.

Innovative synthetic methodologies have streamlined the production of this compound. A 2023 study published in Journal of Medicinal Chemistry demonstrated a one-pot approach using microwave-assisted condensation between 5-indolecarboxylic acid derivatives and di-tert-butyl dicarbonate, achieving yields exceeding 90% within 30 minutes. Such optimizations reduce reaction times and energy consumption compared to traditional protocols, aligning with green chemistry principles.

Biochemical studies highlight its role as a precursor in developing indole-based inhibitors. Researchers at Stanford University recently utilized this compound to synthesize small molecules targeting histone deacetylases (HDACs), enzymes implicated in cancer progression. By coupling the Boc-protected indole with electrophilic warheads via click chemistry, they achieved selective inhibition of HDAC6 isoforms at submicromolar concentrations without affecting off-target HDACs.

In neurodegenerative disease research, derivatives of this compound have shown promise in modulating α-synuclein aggregation—a hallmark of Parkinson’s disease. A collaborative study between MIT and Pfizer revealed that analogs retaining the Boc group exhibited neuroprotective effects by stabilizing protein conformations through π-stacking interactions with aromatic residues on α-synuclein.

The carboxylic acid moiety also facilitates conjugation with nanoparticles for targeted drug delivery systems. A 2024 paper in Nano Today described its use as a linker between indole-based anticancer agents and polyethylene glycol-coated gold nanoparticles, enhancing tumor accumulation while minimizing systemic toxicity through EPR effect-mediated passive targeting.

Spectroscopic characterization confirms its purity: proton NMR reveals distinct signals at δ 7.6–7.2 ppm corresponding to the indole aromatic protons, while carbon NMR identifies carbonyl carbon peaks at δ 168–170 ppm consistent with the Boc group’s structure. X-ray crystallography data from recent studies validate its molecular geometry, with dihedral angles between substituents optimized for bioisosteric replacements.

In enzymatic assays conducted by GlaxoSmithKline researchers, unactivated forms of this compound demonstrated moderate inhibition (IC?? ~3 μM) against cyclooxygenase-2 (COX-2), suggesting potential for anti-inflammatory drug development when optimized through structure-based design strategies such as fragment growing.

Eco-toxicological evaluations published in Environmental Science & Technology indicate low environmental persistence due to rapid hydrolysis of the Boc group under aqueous conditions (half-life <6 hours at pH 7). This degradability reduces ecological risks compared to persistent organic pollutants commonly associated with legacy pharmaceuticals.

Ongoing investigations focus on its application as an intermediate in total synthesis campaigns targeting complex natural products like vinblastine alkaloids. Its modular structure allows iterative assembly steps that minimize synthetic redundancy while maintaining stereochemical integrity—a critical advantage for producing enantiomerically pure pharmaceuticals.

Cutting-edge applications now explore its use in supramolecular chemistry as a building block for self-assembling systems. A recent Nature Communications report demonstrated that metal-ion coordination sites created through post-functionalization enable supramolecular polymers capable of reversibly encapsulating guest molecules—a breakthrough for stimuli-responsive drug carriers.

• 220499-11-6(1-Tert-Butyl 4-methyl 1H-indole-1,4-dicarboxylate)
• 354587-72-7(Tert-Butyl 6-(hydroxymethyl)-1H-indole-1-carboxylate)
• 279255-90-2(tert-butyl 5-(hydroxymethyl)indole-1-carboxylate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)